Dossier - 09/12/2013 Industrial biotechnology biological resources for industrial processes Industrial or white biotechnology uses microorganisms and enzymes to produce goods for industry, including chemicals, plastics, food, agricultural and pharmaceutical products and energy carriers. Renewable raw materials and increasingly also waste from agriculture and forestry are used for the manufacture of industrial goods.https://www.biooekonomie-bw.de/en/articles/dossiers/industrial-biotechnology-biological-resources-for-industrial-processes
Dossier - 02/12/2013 RNA interference confidence is returning The 15-year history of RNA interference is not short on dramatic effects. It begins with the unexpected discovery and publication of the process of post-transcriptional gene silencing in 1998 for which the two Americans Andrew Fire and Craig Mello were awarded the Nobel Prize in Physiology or Medicine just eight years after their discovery. In 2001 Thomas Tuschl succeeded in switching off genes in human cells with small synthetic pieces of RNA…https://www.gesundheitsindustrie-bw.de/en/article/dossier/rna-interference-confidence-is-returning
Dossier - 18/11/2013 Innovative textiles made possible by biotechnology Biotechnology plays a part in many high-tech fabrics that have become an integral part of our everyday life. Whether it is products for the treatment of wounds, fabrics for marquees or for clothing, many materials have been developed or are produced using biotechnological techniques and processes. Many products marketed as “micro” or “nano” are inspired by nature.https://www.gesundheitsindustrie-bw.de/en/article/dossier/innovative-textiles-made-possible-by-biotechnology
Dossier - 18/11/2013 Innovative textiles made possible by biotechnology Biotechnology plays a part in many high-tech fabrics that have become an integral part of our everyday life. Whether it is products for the treatment of wounds, fabrics for marquees or for clothing, many materials have been developed or are produced using biotechnological techniques and processes. Many products marketed as “micro” or “nano” are inspired by nature.https://www.biooekonomie-bw.de/en/articles/dossiers/innovative-textiles-made-possible-by-biotechnology
Dossier - 04/11/2013 Biotechnology driver of innovation in the pharmaceutical industry The biotech industry is the innovative driver for a pharmaceutical industry that, due to the shift from blockbluster products to personalised medicine, now depends on new concepts. The production of new drugs using genetic engineering relies on knowledge gained from genomics, proteomics and systems biology and creates new treatment strategies that combine therapy and diagnostics (i.e. companion diagnostics) to provide a specific individualised…https://www.gesundheitsindustrie-bw.de/en/article/dossier/biotechnology-driver-of-innovation-in-the-pharmaceutical-industry
Dossier - 15/10/2013 Adult stem cells hope for regenerative therapies Adult stem cells have the lifelong ability to generate new specialised cells. They secure the continuous replenishment of cells therefore enabling the constant replacement of dying cells with new ones. Progress in the characterisation isolation and specific differentiation of adult stem cells over recent years raises hopes for the future use of the cells in the therapy of degenerative diseases. Knowledge about adult stem cells also has the…https://www.gesundheitsindustrie-bw.de/en/article/dossier/adult-stem-cells-hope-for-regenerative-therapies
Dossier - 23/09/2013 Bioeconomy a new model for industry and the economy On the one hand, a bioeconomy relies on renewable resources to meet society’s need for food, energy and industrial products. On the other, it emphasises the role of biogenic material flows. The bioeconomy model is expected to reduce our dependency on fossil fuels in the long term. In order to implement the shift to a biobased economy on the regional level, the Baden-Württemberg government launched the Bioeconomy Research Strategy in summer 2013.https://www.biooekonomie-bw.de/en/articles/dossiers/bioeconomy-a-new-model-for-industry-and-the-economy
Dossier - 19/08/2013 Telemedicine advances in high-tech healthcare Increasing average longevity, the growing number of chronic diseases and health economy issues are all generating an ever-increasing demand for inexpensive therapy options that are not time - or location dependent. Telemedicine has been offering advanced solutions for a broad range of medical and health issues. Despite this progress, the use of telecommunication and information technologies in the provision of remote healthcare services appears…https://www.gesundheitsindustrie-bw.de/en/article/dossier/telemedicine-advances-in-high-tech-healthcare
Dossier - 05/08/2013 Progress expands bioethical boundaries Bioethics is a rich and continually evolving field. In the broadest sense, bioethics relates to the way human individuals treat any form of life. The issue of whether human beings have the right to do whatever they want goes way back. Rapid progress in genetic engineering and cell biology means that it is necessary to look at certain issues in a new way and recognise that not everything that is technically feasible should actually be carried out.https://www.gesundheitsindustrie-bw.de/en/article/dossier/progress-expands-bioethical-boundaries
Dossier - 03/06/2013 Food analytics applied consumer protection Consumers rightly expect to be supplied with healthy, high-quality and safe foods. However, over the past few years, food scandals have frequently hit the headlines. They are brought to light in laboratories that have a huge arsenal of methods and procedures to analyse food. Although the media would have us believe otherwise, the vast majority of foods are safe and very rarely hazardous to human health.https://www.gesundheitsindustrie-bw.de/en/article/dossier/food-analytics-applied-consumer-protection
Dossier - 21/05/2013 No new drugs to be placed on the market without clinical trials New pharmaceuticals are subject to approval by drug authorities. Here clinical trials are performed to ensure the quality efficacy and safety of a medicinal product. Clinical development is a time-consuming and costly process and takes on average ten to fifteen years before a pharmaceutical company can apply for the approval of the drug. The costs including failures can amount to approximately one billion US dollars per drug.https://www.gesundheitsindustrie-bw.de/en/article/dossier/no-new-drugs-to-be-placed-on-the-market-without-clinical-trials
Dossier - 05/11/2012 Cancer basic research successes and trends Science is approaching cancer treatment by using new systems biology approaches and setting up large-scale multidisciplinary projects such as the International Cancer Genome Consortium. Progress in genome, epigenome and gene expression analyses of cancer cells, new insights into the regulation and interaction of cells gained in cooperation with stem cell research and virus research contributes to gaining a causal understanding of cancer.https://www.gesundheitsindustrie-bw.de/en/article/dossier/cancer-basic-research-successes-and-trends
Dossier - 22/10/2012 Environmental biotechnology Biotechnologists are increasingly learning how to apply the knowledge about biological metabolic processes in the field of environmental protection including waste management and environmental rehabilitation. Environmental biotechnology is a field with great potential. In future bacteria and other microorganisms will most likely also contribute to sustainability and cost efficiency in other areas including the cosmetics and detergent industry as…https://www.biooekonomie-bw.de/en/articles/dossiers/environmental-biotechnology
Dossier - 08/10/2012 Marine biotechnology unknown sources of hope from the depths of the sea Biotechnological methods are used to investigate marine life and the results obtained from these investigations advance research in the fields of medicine and energy and into substances used as food supplements and cosmetics. The area of marine biotechnology is fairly diverse. Although it is not on the coast even the southern German state of Baden-Württemberg is involved in marine biotechnology.https://www.gesundheitsindustrie-bw.de/en/article/dossier/marine-biotechnology-unknown-sources-of-hope-from-the-depths-of-the-sea
Dossier - 08/10/2012 Marine biotechnology unknown sources of hope from the depths of the sea Biotechnological methods are used to investigate marine life and the results obtained from these investigations advance research in the fields of medicine and energy and into substances used as food supplements and cosmetics. The area of marine biotechnology is fairly diverse. Although it is not on the coast even the southern German state of Baden-Württemberg is involved in marine biotechnology.https://www.biooekonomie-bw.de/en/articles/dossiers/marine-biotechnology-unknown-sources-of-hope-from-the-depths-of-the-sea
Dossier - 01/10/2012 Systems biology understanding complex biological systems Systems biology studies complex interactions within biological systems on the genome proteome and organelle level. Many techniques from the fields of systems theory and associated fields can be used to gain an understanding of the behaviour and biological mechanisms of cellular systems.https://www.gesundheitsindustrie-bw.de/en/article/dossier/systems-biology-understanding-complex-biological-systems
Dossier - 01/10/2012 Systems biology understanding complex biological systems Systems biology studies complex interactions within biological systems on the genome proteome and organelle level. Many techniques from the fields of systems theory and associated fields can be used to gain an understanding of the behaviour and biological mechanisms of cellular systems.https://www.biooekonomie-bw.de/en/articles/dossiers/systems-biology-understanding-complex-biological-systems
Dossier - 10/09/2012 Horizon 2020 the EU framework programme for research and innovation a boost for top-level research in Europe In the face of the ongoing financial crisis Europe is working on a new research strategy that is aimed at creating new economic growth and jobs. The new EU framework programme for research and innovation Horizon 2020 replaces the 7th Framework Programme FP7 and will run from 2014 with a budget of 80 billion. In July 2012 Brussels launched the final FP7 calls for proposals for 2013 that offer numerous market-based instruments designed to bridge…https://www.gesundheitsindustrie-bw.de/en/article/dossier/horizon-2020-the-eu-framework-programme-for-research-and-innovation-a-boost-for-top-level-research-i
Dossier - 10/09/2012 Horizon 2020 the EU framework programme for research and innovation a boost for top-level research in Europe In the face of the ongoing financial crisis Europe is working on a new research strategy that is aimed at creating new economic growth and jobs. The new EU framework programme for research and innovation Horizon 2020 replaces the 7th Framework Programme FP7 and will run from 2014 with a budget of 80 billion. In July 2012 Brussels launched the final FP7 calls for proposals for 2013 that offer numerous market-based instruments designed to bridge…https://www.biooekonomie-bw.de/en/articles/dossiers/horizon-2020-the-eu-framework-programme-for-research-and-innovation-a-boost-for-top-level-research-i
Dossier - 23/07/2012 Extremophilic bacteria Extremophilic bacteria love it hot, sour or salty, toxic substances like heavy metals also do them good and even give them energy. As molecular and systems biology techniques get better and better, industry is also becoming increasingly interested in these exotic organisms. What potential does knowing the biochemistry of extremophilic bacteria have for the pharmaceutical, cosmetics and sanitary articles industries? https://www.gesundheitsindustrie-bw.de/en/article/dossier/extremophilic-bacteria
Dossier - 23/07/2012 Extremophilic bacteria Extremophilic bacteria love it hot, sour or salty, toxic substances like heavy metals also do them good and even give them energy. As molecular and systems biology techniques get better and better, industry is also becoming increasingly interested in these exotic organisms. What potential does knowing the biochemistry of extremophilic bacteria have for the pharmaceutical, cosmetics and sanitary articles industries? https://www.biooekonomie-bw.de/en/articles/dossiers/extremophilic-bacteria
Dossier - 18/06/2012 Biobanks treasure chests for biomedical research The Research Committee at the German Bundestag, the Office of Technology Assessment at the German Bundestag and the German Ethics Council are all interested in this biomedical research tool, which is both necessary and meaningful. However, opinions with regard to the ethical, legal and technical approach to biobanks differ. Since March 2012 it has become absolutely clear that Germany will not pass a biobanking law during the current mandate. https://www.gesundheitsindustrie-bw.de/en/article/dossier/biobanks-treasure-chests-for-biomedical-research